Literature DB >> 10921931

Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections.

Y W Hu1, E Balaskas, M Furione, P H Yen, G Kessler, V Scalia, L Chui, G Sher.   

Abstract

To date the true prevalence of hepatitis C virus (HCV) mixed-genotype infections has not been established mainly because currently available methods are not suitable for the detection of mixed genotypes in a viral population. A novel semiautomated genotyping method, primer-specific and mispair extension analysis (S-PSMEA), which is more reliable than other genotyping assays was developed for detection of HCV mixed-genotype infections. A genotype present at levels as low as 0.8% in a defined mix of HCV genotypes was detected, showing a 20-fold increase in sensitivity over that of direct DNA sequencing. A total of 434 HCV isolates were genotyped and analyzed for a comparative study of the accuracy between S-PSMEA and four current genotyping methods. The results showed that viruses in approximately 40% of the samples from this group determined to be infected with mixed genotypes by S-PSMEA were undetected by direct DNA sequencing due to its low sensitivity. Type-specific PCR, line probe assay, and restriction fragment length polymorphism analysis performed poorly, being able to identify only 38.5, 16.1, and 15.4% of mixed-genotype infections, respectively, that were detected by direct DNA sequencing. The prevalence of mixed-genotype infections detected by S-PSMEA was 7.9% (12 of 152 donors) among HCV-infected blood donors, 14.3% (15 of 105) among patients with chronic hepatitis C, and 17.1% (6 of 36) among thalassemia patients who had received multiple transfusions. The data lead us to conclude that HCV mixed-genotype infections are more common than previously estimated and that S-PSMEA may be the method of choice when detection of genotypes present at low levels in mixed-genotype infections is required due to its higher level of sensitivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921931      PMCID: PMC87116     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.

Authors:  L Stuyver; W van Arnhem; A Wyseur; F Hernandez; E Delaporte; G Maertens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 2.  Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.

Authors:  J Bukh; R H Miller; R H Purcell
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

3.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors:  R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

4.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

Authors:  N Ogata; H J Alter; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

Authors:  H Okamoto; H Tokita; M Sakamoto; M Horikita; M Kojima; H Iizuka; S Mishiro
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

6.  Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs.

Authors:  L M Jarvis; H G Watson; F McOmish; J F Peutherer; C A Ludlam; P Simmonds
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

7.  Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States.

Authors:  J Y Lau; M Mizokami; J A Kolberg; G L Davis; L E Prescott; T Ohno; R P Perrillo; K L Lindsay; R G Gish; K P Qian
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

8.  Genotyping of Canadian hepatitis C virus isolates by PCR.

Authors:  A Andonov; R K Chaudhary
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

9.  Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children.

Authors:  M E Lai; A P Mazzoleni; F Argiolu; S De Virgilis; A Balestrieri; R H Purcell; A Cao; P Farci
Journal:  Lancet       Date:  1994-02-12       Impact factor: 79.321

Review 10.  Variability of hepatitis C virus.

Authors:  P Simmonds
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

View more
  20 in total

1.  Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Authors:  C Matheï; E Wollants; J Verbeeck; M Van Ranst; G Robaeys; P Van Damme; F Buntinx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

2.  Surveillance of viral contamination of invasive medical instruments in dentistry.

Authors:  Lin-fu Zhou; Hai-hong Zhu; Jun Lin; Min-jun Hu; Feng Chen; Zhi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2006-09       Impact factor: 3.066

Review 3.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  Rapid genotyping of hepatitis C virus by primer-specific extension analysis.

Authors:  Nick A Antonishyn; Vivian M Ast; Ryan R McDonald; Rabindra K Chaudhary; Lisa Lin; Anton P Andonov; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.

Authors:  Andrew J Buckton; Siew-Lin Ngui; Catherine Arnold; Katie Boast; Joanne Kovacs; Paul E Klapper; Bharat Patel; Imad Ibrahim; Savita Rangarajan; Mary E Ramsay; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 6.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

7.  A shift in the hepatitis C virus genotype dominance in blood donor samples from Thailand.

Authors:  Anchalee Sistayanarain; Duangkamol Kunthalert; Yaovaluk Vipsoongnern
Journal:  Mol Biol Rep       Date:  2010-11-27       Impact factor: 2.316

8.  Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions.

Authors:  Suwanna Noppornpanth; Erwin Sablon; Kathy De Nys; Xuan Lien Truong; Jan Brouwer; Marianne Van Brussel; Saskia L Smits; Yong Poovorawan; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

9.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

10.  HCV genotyping using statistical classification approach.

Authors:  Ping Qiu; Xiao-Yan Cai; Wei Ding; Qing Zhang; Ellie D Norris; Jonathan R Greene
Journal:  J Biomed Sci       Date:  2009-07-08       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.